BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ludwig Institute For Cancer Research (LICR) 

605 Third Avenue

New York  New York  10158  U.S.A.
Phone: 212-450-1543 Fax: 212-450-1555


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Healthcare






 Company News
CureVac GmbH Collaborates With the Cancer Research Institute and Ludwig Institute For Cancer Research (LICR) to Enable Clinical Testing of Novel Immunotherapy Treatment Options for Cancer 11/4/2013 10:37:24 AM
Mapping the Embryonic Epigenome, Ludwig Institute For Cancer Research (LICR), Salk Institute for Biological Studies, and Morgridge Insitute for Research Study 5/10/2013 7:50:28 AM
4-Antibody AG and the Ludwig Institute For Cancer Research (LICR) Expand Oncology Antibody R&D Program With Three New Targets 1/29/2013 11:04:22 AM
Powerful Sequencing Technology Decodes DNA Folding Pattern, Ludwig Institute For Cancer Research (LICR) Study 4/12/2012 7:03:17 AM
4-Antibody AG Forms Multi-target Oncology Research and Development Alliance with the Ludwig Institute For Cancer Research (LICR) 5/24/2011 10:27:30 AM
Ludwig Institute For Cancer Research (LICR) and Polaris Form Collaboration to Expand Development of Polaris' Novel Cancer Drug, ADI-PEG 20 5/18/2011 9:15:10 AM
Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Discover That DAVANAT(R) Enhances the Ability of Anti-Tumor T Lymphocytes to Kill Tumor Cells 4/20/2011 8:45:23 AM
Lethal Brain Tumor's Strength May Be a Weakness as Well, Reveals Ludwig Institute For Cancer Research (LICR) 8/17/2010 6:20:19 AM
Pro-Pharmaceuticals, Inc. (PRW) Announces Significant Advance in Defining DAVANAT(R)'s Mechanism of Action Based on Experiments Done at the University of Minnesotaand the Ludwig Institute For Cancer Research (LICR) in Brussels, Belgium 12/17/2009 9:39:03 AM
The Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Collaborate to Test DAVANAT(R)'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes 12/15/2009 9:03:48 AM
1234